CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
Stimgenics SCS Programming Approach +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03606187
NCT03606187N/ACompleted
CompareCT.gov

Stimgenics Open-Label, Post Market Study: A Clinical Trial to Study the Effects of Stimgenics Spinal Cord Stimulation (SGX-SCS) Programs in Treating Intractable Chronic Back Pain

Stimgenics LLC·interventional·Posted Jul 30, 2018·Updated Mar 2, 2021

In Brief

A clinical study evaluating Stimgenics SCS Programming Approach and Standard SCS Programming Approach for Chronic Low Back Pain. Completed, enrolled 128 participants across 1 site.

Detailed Summary

The purpose of this investigational study is to study the effects of Stimgenics Spinal Cord Stimulation (SGX-SCS) in subjects with chronic, intractable pain of the trunk with lower limb pain, including unilateral or bilateral pain associated with the following conditions: failed back surgery syndrome, intractable low back pain and leg pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Low Back Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 30, 2018
Enrollment StartJun 26, 2018
Primary CompletionNov 8, 2019
Study CompletionJul 22, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.9 years ago

Interventions

Stimgenics SCS Programming Approachdevice

Stimgenics SCS Programming approach Using Intellis(TM) SCS system

Standard SCS Programming Approachdevice

Standard SCS Programming approach using Intellis(TM) SCS system